164 related articles for article (PubMed ID: 36246939)
1. Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia: Two Randomized Phase 2 Studies.
Price FW; Hom M; Moshirfar M; Evans D; Liu H; Penzner J; Robinson MR; Lee S; Wirta DL
Ophthalmol Sci; 2021 Dec; 1(4):100065. PubMed ID: 36246939
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Twice-Daily Pilocarpine HCl in Presbyopia: The Virgo Phase 3, Randomized, Double-Masked, Controlled Study.
Kannarr S; El-Harazi SM; Moshirfar M; Lievens C; Kim JL; Peace JH; Safyan E; Liu H; Zheng S; Robinson MR
Am J Ophthalmol; 2023 Sep; 253():189-200. PubMed ID: 37149245
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial.
Waring GO; Price FW; Wirta D; McCabe C; Moshirfar M; Guo Q; Gore A; Liu H; Safyan E; Robinson MR
JAMA Ophthalmol; 2022 Apr; 140(4):363-371. PubMed ID: 35238902
[TBL] [Abstract][Full Text] [Related]
4. Impact of presbyopia treatment pilocarpine hydrochloride 1.25% on night-driving performance.
Waring GO; Brujic M; McGee S; Micheletti JM; Zhao C; Schachter S; Liu H; Safyan E
Clin Exp Optom; 2023 Dec; ():1-8. PubMed ID: 38044272
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochloride) in Presbyopia: Pooled Results of the NEAR Phase 3 Randomized, Clinical Trials.
Holland E; Karpecki P; Fingeret M; Schaeffer J; Gupta P; Fram N; Smits G; Ignacio T; Lindstrom R
Clin Ther; 2024 Feb; 46(2):104-113. PubMed ID: 38216351
[TBL] [Abstract][Full Text] [Related]
6. Presbyopia Treatment With Eye Drops: An Eight Year Retrospective Study.
Benozzi G; Perez C; Leiro J; Facal S; Orman B
Transl Vis Sci Technol; 2020 Jun; 9(7):25. PubMed ID: 32832231
[TBL] [Abstract][Full Text] [Related]
7. Femtosecond laser-assisted in situ keratomileusis multifocal ablation profile using a mini-monovision approach for presbyopic patients with hyperopia.
Vastardis I; Pajic-Eggspühler B; Müller J; Cvejic Z; Pajic B
Clin Ophthalmol; 2016; 10():1245-56. PubMed ID: 27478365
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Presbyopia in Emmetropes Using a Shape-Changing Corneal Inlay: One-Year Clinical Outcomes.
Whitman J; Dougherty PJ; Parkhurst GD; Olkowski J; Slade SG; Hovanesian J; Chu R; Dishler J; Tran DB; Lehmann R; Carter H; Steinert RF; Koch DD
Ophthalmology; 2016 Mar; 123(3):466-75. PubMed ID: 26804761
[TBL] [Abstract][Full Text] [Related]
9. A multicentric study of pharmacological treatment for presbyopia.
Benozzi G; Cortina ME; Gimeno E; Vantesone DL; Solas AE; Lorda GM; Facal S; Leiro J; Orman B
Graefes Arch Clin Exp Ophthalmol; 2021 Aug; 259(8):2441-2450. PubMed ID: 33704563
[TBL] [Abstract][Full Text] [Related]
10. Ciliary Muscle Electrostimulation to Restore Accommodation in Patients With Early Presbyopia: Preliminary Results.
Gualdi L; Gualdi F; Rusciano D; Ambrósio R; Salomão MQ; Lopes B; Cappello V; Fintina T; Gualdi M
J Refract Surg; 2017 Sep; 33(9):578-583. PubMed ID: 28880331
[TBL] [Abstract][Full Text] [Related]
11. Distance and near visual acuity improvement after implantation of multifocal intraocular lenses in cataract patients with presbyopia: a systematic review.
Agresta B; Knorz MC; Kohnen T; Donatti C; Jackson D
J Refract Surg; 2012 Jun; 28(6):426-35. PubMed ID: 22692525
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment.
Jackson MA; Giyanani J; Shabaik Y; Penzner J; Gore AV; Robinson MR; Waring GO
Ophthalmol Ther; 2022 Apr; 11(2):869-879. PubMed ID: 35235173
[TBL] [Abstract][Full Text] [Related]
13. Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials.
Slonim CB; Foster S; Jaros M; Kannarr SR; Korenfeld MS; Smyth-Medina R; Wirta DL
JAMA Ophthalmol; 2020 Nov; 138(11):1168-1175. PubMed ID: 33001144
[TBL] [Abstract][Full Text] [Related]
14. Understanding Perspectives on Presbyopia and Use of Pilocarpine HCl 1.25% Twice Daily from Participants of the Phase 3 VIRGO Study.
Shafer BM; McGee SR; Ifantides C; Williamson BK; Kannarr S; Whyte J; Zhang Z; Yanke T; Schachter S
Ophthalmol Ther; 2024 Jun; 13(6):1723-1742. PubMed ID: 38662193
[TBL] [Abstract][Full Text] [Related]
15. Preloaded refractive-addition corneal inlay to compensate for presbyopia implanted using a femtosecond laser: one-year visual outcomes and safety.
Baily C; Kohnen T; O'Keefe M
J Cataract Refract Surg; 2014 Aug; 40(8):1341-8. PubMed ID: 25088635
[TBL] [Abstract][Full Text] [Related]
16. Effects of Miosis on the Visual Acuity Space under Varying Conditions of Contrast and Ambient Luminance in Presbyopia.
Onyszkiewicz M; Hilmers J; Rejdak R; Zrenner E; Straßer T
J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592033
[No Abstract] [Full Text] [Related]
17. Femtosecond laser-assisted small-aperture corneal inlay implantation for corneal compensation of presbyopia: two-year follow-up.
Seyeddain O; Bachernegg A; Riha W; Rückl T; Reitsamer H; Grabner G; Dexl AK
J Cataract Refract Surg; 2013 Feb; 39(2):234-41. PubMed ID: 23245507
[TBL] [Abstract][Full Text] [Related]
18. Visual function through 4 contact lens-based pinhole systems for presbyopia.
García-Lázaro S; Ferrer-Blasco T; Radhakrishnan H; Cerviño A; Charman WN; Montés-Micó R
J Cataract Refract Surg; 2012 May; 38(5):858-65. PubMed ID: 22424803
[TBL] [Abstract][Full Text] [Related]
19. Unilateral Refractive Lens Exchange with a Multifocal Intraocular Lens in Emmetropic Presbyopic Patients.
Levinger E; Levinger S; Mimouni M; Trivizki O; Levinger N; Barequet IS; Rabina G
Curr Eye Res; 2019 Jul; 44(7):726-732. PubMed ID: 30841762
[No Abstract] [Full Text] [Related]
20. Pharmacological Treatment of Presbyopia by Novel Binocularly Instilled Eye Drops: A Pilot Study.
Renna A; Vejarano LF; De la Cruz E; Alió JL
Ophthalmol Ther; 2016 Jun; 5(1):63-73. PubMed ID: 27168149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
